(2026). Neoadjuvant versus adjuvant chemoradiotherapy for resectable cT3‐4a esophageal squamous cell carcinoma: A matched cohort analysis. Precision Radiation Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Neoadjuvant Versus Adjuvant Chemoradiotherapy for Resectable CT3‐4a Esophageal Squamous Cell Carcinoma: A Matched Cohort Analysis."
Precision Radiation Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Neoadjuvant Versus Adjuvant Chemoradiotherapy for Resectable CT3‐4a Esophageal Squamous Cell Carcinoma: A Matched Cohort Analysis."
Precision Radiation Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.